The results indicated an increase in MS4A4A, HLA‐DMB, LY86, MS4A7, and FOLR2 expression in GBM tumor samples compared to normal tissue samples (n = 706) (Figure 2D). This evidence concerns the gene LY86 and glioblastoma.